EMPOWER-Cervical 1 (GOG-3016 / ENGOT-cx9): Cemiplimab vs. Chemotherapy in Recurrent/Metastatic Cervical Cancer Last updated on Jun 8, 2026 Previous PORTEC-4a: Molecular Profile-Based Adjuvant Treatment for High-Intermediate Risk Endometrial Cancer Next GROINSS-V I: Sentinel Node Dissection as Sole Groin Staging in Early-Stage Vulvar Cancer
